Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANRENONE vs CAPMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANRENONE vs CAPMATINIB: Safety Overview

Metric CANRENONE CAPMATINIB
Total FAERS Reports 286 2,301
Deaths Reported 19 583
Death Rate 6.6% 25.3%
Hospitalizations 199 388
Average Patient Age 69.0 yrs 71.9 yrs
% Female Patients 51.8% 53.9%
FDA Approval Date N/A May 6, 2020
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status N/A Prescription